Melanophages reside in hypermelanotic, aberrantly glycosylated tumor areas and predict improved outcome in primary cutaneous malignant melanoma

Journal of Cutaneous Pathology

Volumn 34, Issue 9, 2007, Pages 679-686

  Handerson, Tamara ^a   Berger, Aaron ^b   Harigopol, Malini ^b   Rimm, David ^b   Nishigori, Chikako ^c   Ueda, Masato ^c   Miyoshi, Eiji ^d   Taniguchi, Naoyuki ^d   Pawelek, John ^b,e  

^a GREENWICH HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^e YALE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGOSACCHARIDE;

ARTICLE; BONE MARROW CELL; BREAST CARCINOMA; CANCER CELL; CANCER SURVIVAL; CELL MOTILITY; CELL TYPE; COLON CARCINOMA; FOLLOW UP; GLYCOSYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE SYSTEM; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MELANOCYTE; MELANOMA; MELANOMA CELL; MELANOPHAGE; PIGMENTATION; PROGNOSIS; TISSUE MICROARRAY;

GLYCOSYLATION; HISTIOCYTES; HUMANS; JAPAN; MELANINS; MELANOCYTES; MELANOMA; OLIGOSACCHARIDES, BRANCHED-CHAIN; SKIN NEOPLASMS; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 34547875374     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2006.00681.x     Document Type: Article

References (37)

1. Saleh FH, Crotty KA, Hersey P, Menzies SW, Rahman W. Autonomous histopathological regression of primary tumours associated with specific immune responses to cancer antigens. J Pathol 2003 200 : 383.
2. Liszkay G, Orosz Z, Peley G, et al. Relationship between sentinel lymph node status and regression of primary malignant melanoma. Melanoma Res 2005 15 : 509.
3. Handerson T, Pawelek J. β1,6-Branched oligosaccharides and coarse vesicles: a common and pervasive phenotype in melanoma and other human cancers. Cancer Res 2003 63 : 5363.
4. Halliday GM, Patel A, Hunt MJ, Tefany FJ, Barnetson RS. Spontaneous regression of human melanoma/nonmelanoma skin cancer: association with infiltrating CD4+ T cells. World J Surg 1995 19 : 352.
5. Bingle L, Brown NJ, Lewis CE. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 2002 196 : 254.
6. Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006 24 : 263.
7. Makitie T, Summanen P, Tarkkanen A, Kivela T. Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma. Invest Ophthalmol Vis Sci 2001 42 : 1414.
8. Kerr KM, Johnson SK, King G, Kennedy MM, Weir J, Jeffrey R. Partial regression in primary carcinoma of the lung: does it occur? Histopathology 1998 33 : 55.
9. Shimura S, Yang G, Ebara S, Wheeler TM, Frolov A, Thompson TC. Reduced infiltration of tumour-associated macrophages in human prostate cancer: association with cancer progression. Cancer Res 2000 60 : 5857.
10. Migita T, Sato E, Saito K, et al. Differing expression of MMPs-1 and 9 and urokinase receptor between diffuse and intestinal type gastric carcinoma. Int J Cancer 1999 84 : 74.
11. Kamino H, Tam ST. Immunoperoxidase technique modified by counterstain with azure B as a diagnostic aid in evaluating heavily pigmented melanocytic neoplasms. J Cutan Pathol 1991 18 : 436.
12. Kligora CJ, Fair KP, Clem MS, Patterson JW. A comparison of melanin bleaching and azure blue counterstaining in the immunohistochemical diagnosis of malignant melanoma. Mod Pathol 1999 12 : 1143.
13. Davis DA, Kurtz KA, Robinson RA. Ultrarapid staining for cutaneous melanoma: study and protocol. Dermatol Surg 2005 31 : 753, discussion 756.
14. Berger AJ, Camp RL, Divito KA, Kluger HM, Halaban R, Rimm DL. Automated quantitative analysis of HDM2 expression in malignant melanoma shows association with early-stage disease and improved outcome. Cancer Res 2004 64 : 8767.
15. Toivonen P, Makitie T, Kujala E, Kivela T. Microcirculation and tumor-infiltrating macrophages in choroidal and ciliary body melanoma and corresponding metastases. Invest Ophthalmol Vis Sci 2004 45 : 1.
16. Bolognia JL, Lin A, Shapiro PE. The significance of eccentric foci of hyperpigmentation ('small dark dots') within melanocytic nevi. Analysis of 59 cases. Arch Dermatol 1994 130 : 1013.
17. Huynh PM, Glusac EJ, Bolognia JL. The clinical appearance of clonal nevi (inverted type A nevi). Int J Dermatol 2004 43 : 882.
18. Brocker EB, Zwadlo G, Holzmann B, Macher E, Sorg C. Inflammatory cell infiltrates in human melanoma at different stages of tumor progression. Int J Cancer 1988 41 : 562.
19. Torisu H, Ono M, Kiryu H, et al. Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNF alpha and IL-1 alpha. Int J Cancer 2000 85 : 182.
20. Varney ML, Johansson SL, Singh RK. Tumour-associated macrophage infiltration, neovascularization and aggressiveness in malignant melanoma: role of monocyte chemotactic protein-1 and vascular endothelial growth factor-A. Melanoma Res 2005 15 : 417.
21. Dennis JW, Laferte S, Waghorne C, Breitman ML, Kerbel RS. β1-6 Branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 1987 236 : 582.
22. Fernandes B, Sagman U, Auger M, Demetrio M, Dennis JW. β1,6-Branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. Cancer Res 1991 51 : 718.
23. Handerson, T, Camp R, Harigopal M, Rimm D, Pawelek J. β1,6-Branched oligosaccharides are associated with metastasis and predict poor outcome in breast carcinoma. Clin Can Res 2005 11 : 2969.
24. Seelentag WK, Li WP, Schmitz SF, et al. Pronostic value of beta 1,6-branched oligosaccharides in human colorectal carcinoma. Cancer Res 1998 58 : 5559.
25. Murata K, Miyoshi E, Kameyama M, et al. Expression of N-acetylglucosaminyltransferase V in colorectal cancer correlates with metastasis and poor prognosis. Clin Cancer Res 2000 6 : 1772.
26. Dosaka-Akita H, Miyoshi E, Suzuki O, Itoh T, Katoh H, Taniguchi N. Expression of N-acetylglucosaminyltransferase V is associated with prognosis and histology in non-small cell lung cancers. Clin Cancer Res 2004 10 : 1773.
27. Dick W. Melanosis in men and horses (letter). Lancet 1832 192.
28. Clark WH, Mastangelo MJ, Ainsworth AM, Berd D, Bellet RE, Bernardino EA. Current concepts of the biology of human cutaneous malignant melanoma. Adv Cancer Res 1977 24 : 267.
29. Crowson AN, Magro CM, Mihm MC Jr. Malignant melanoma with prominent pigment synthesis: "animal type" melanoma - a clinical and histological study of six cases with a consideration of other melanocytic neoplasms with prominent pigment synthesis. Hum Pathol 1999 30 : 543.
30. Magro CM, Crowson AN, Mihm MC. Unusual variants of malignant melanoma. Mod Pathol 2006 19 (Suppl. 2 S41.
31. Horikoshi T, Jimbow K, Sugiyama S. Comparison of macromelanosomes and autophagic giant melanosome complexes in nevocellular nevi, lentigo simplex and malignant melanoma. J Cutan Pathol 1982 5 : 329.
32. Yamashita K, Ohkura T, Tachibana Y, Takasaki S, Kobata A. Comparative study of the oligosaccharides released from baby hamster kidney cells and their polyoma transformant by hydrazinolysis. J Biol Chem 1984 259 : 10834.
33. Brockhausen I, Narasimhan S, Schachter H. The biosynthesis of highly branched N-glycans: studies on the sequential pathway and functional role of N-acetylglucosaminyltransferases I, II, III, IV, V and VI. Biochimie 1988 70 : 1521.
34. Hakomori S. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res 1996 56 : 5309.
35. Hariri M, Millane G, Guimond M, Guay G, Dennis JW, Nabi IR. Biogenesis of multilamellar bodies via autophagy. Mol Biol Cell 2000 11 : 255.
36. Chakraborty AK, Pawelek J. β1,6-Branched oligosaccharides regulate melanin content and motility in macrophage-melanoma fusion hybrids. Melanoma Res, in press.
37. Nesbit M, Schaider H, Miller TH, Herlyn M. Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells. J Immunol 2001 166 : 6483.